Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Provision Cancer Center is a commercial-stage outpatient oncology center in Knoxville, Tennessee that integrates cancer diagnostics, radiation therapy, theranostics, radiopharmacy, and clinical trial access in a single site of care. It operates within the broader Provision Health Services and Provision Healthcare ecosystem, which also develops proton therapy and related oncology technologies. The center emphasizes precision oncology services including advanced imaging, adaptive radiation therapy, and theranostics for prostate cancer. Current marketed offerings highlighted by the organization include diagnostic imaging, Varian Ethos-based adaptive radiation therapy, and Pluvicto-based theranostics. Provision Cancer Center appears to function primarily as a care delivery organization rather than a drug development biotech with a proprietary therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Provision Cancer Center.